AF
INFI

Amalgamated Financial’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Amalgamated Financial’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$16K Buy
+13,875
New +$16.6K ﹤0.01% 2807

Other funds holding INFI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Amalgamated Financial's INFI Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Infinity Pharmaceuticals, Inc. (INFI) in Q1 2022: 13,875 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #2807 among its holdings.

93 funds tracked by Wall St. Rank hold INFI as of Q1 2022.

  • Amalgamated Financial held 13,875 shares of Infinity Pharmaceuticals, Inc. worth $16K as of Q1 2022.
  • Infinity Pharmaceuticals, Inc. was a new Amalgamated Financial position in Q1 2022.
  • Infinity Pharmaceuticals, Inc. made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2807 holding.
  • 93 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.